Cargando…

A genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways that mediate resistance to sorafenib in acute myeloid leukemia

Drug resistance impedes the long-term effect of targeted therapies in acute myeloid leukemia (AML), necessitating the identification of mechanisms underlying resistance. Approximately 25% of AML patients carry FLT3 mutations and develop post-treatment insensitivity to FLT3 inhibitors, including sora...

Descripción completa

Detalles Bibliográficos
Autores principales:	Damnernsawad, Alisa, Bottomly, Daniel, Kurtz, Stephen E., Eide, Christopher A., McWeeney, Shannon K., Tyner, Jeffrey W., Nechiporuk, Tamilla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719098/ https://www.ncbi.nlm.nih.gov/pubmed/33375770 http://dx.doi.org/10.3324/haematol.2020.257964

Ejemplares similares

Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia
por: Kurtz, Stephen E., et al.
Publicado: (2022)

Immune cell proportions correlate with clinicogenomic features and ex vivo drug responses in acute myeloid leukemia
por: Romine, Kyle A., et al.
Publicado: (2023)

Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphoma
por: Thieme, Elana, et al.
Publicado: (2022)

Luxeptinib (CG-806) Targets FLT3 and Clusters of Kinases Operative in Acute Myeloid Leukemia
por: Rice, William G., et al.
Publicado: (2022)

Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms
por: Zhang, Haijiao, et al.
Publicado: (2019)

ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia
por: Joshi, Sunil K., et al.
Publicado: (2020)

HitWalker: variant prioritization for personalized functional cancer genomics
por: Bottomly, Daniel, et al.
Publicado: (2013)

Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia
por: Lachowiez, Curtis A., et al.
Publicado: (2022)

plethy: management of whole body plethysmography data in R
por: Bottomly, Daniel, et al.
Publicado: (2015)

HitWalker2: visual analytics for precision medicine and beyond
por: Bottomly, Daniel, et al.
Publicado: (2016)

Identification of β-catenin binding regions in colon cancer cells using ChIP-Seq
por: Bottomly, Daniel, et al.
Publicado: (2010)

Comprehensive molecular characterization of a rare case of Philadelphia chromosome–positive acute myeloid leukemia
por: Rosenberg, Mara W., et al.
Publicado: (2022)

Comparison of methods to identify aberrant expression patterns in individual patients: augmenting our toolkit for precision medicine
por: Bottomly, Daniel, et al.
Publicado: (2013)

Detection of Expression Quantitative Trait Loci in Complex Mouse Crosses: Impact and Alleviation of Data Quality and Complex Population Substructure
por: Iancu, Ovidiu D., et al.
Publicado: (2012)

Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations
por: Zhang, Haijiao, et al.
Publicado: (2017)

A Single-Cell Approach to the Elusive Latent Human Cytomegalovirus Transcriptome
por: Goodrum, Felicia, et al.
Publicado: (2018)

Functional proteomics of patient derived head and neck squamous cell carcinoma cells reveal novel applications of trametinib
por: Vigoda, Myles, et al.
Publicado: (2022)

Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia
por: Lamble, Adam J., et al.
Publicado: (2020)

Lentiviral-Driven Discovery of Cancer Drug Resistance Mutations
por: Yenerall, Paul, et al.
Publicado: (2021)

Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation
por: Gao, Lina, et al.
Publicado: (2013)

The genetics of gene expression in complex mouse crosses as a tool to study the molecular underpinnings of behavior traits
por: Hitzemann, Robert, et al.
Publicado: (2013)

Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib
por: Macias, Rocio I.R., et al.
Publicado: (2018)

Murine Models of Acute Myeloid Leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2022)

Localization of TFIIB binding regions using serial analysis of chromatin occupancy
por: Yochum, Gregory S, et al.
Publicado: (2007)

Quantitative Trait Locus Analysis: Multiple Cross and Heterogeneous Stock Mapping
por: Hitzemann, Robert, et al.
Publicado: (2008)

In vivo genome-wide CRISPR screening in murine acute myeloid leukemia uncovers microenvironmental dependencies
por: Mercier, Francois E., et al.
Publicado: (2022)

On the Relation of the Parasitic Protozoa to Each Other and to Human Disease
por: McWeeney, E. J.
Publicado: (1905)

Corrigendum: Murine models of acute myeloid leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2023)

High throughput sequencing in mice: a platform comparison identifies a preponderance of cryptic SNPs
por: Walter, Nicole AR, et al.
Publicado: (2009)

Evaluating Gene Expression in C57BL/6J and DBA/2J Mouse Striatum Using RNA-Seq and Microarrays
por: Bottomly, Daniel, et al.
Publicado: (2011)

Functional Genomic Landscape of Acute Myeloid Leukemia
por: Tyner, Jeffrey W., et al.
Publicado: (2018)

Venetoclax Overcomes Sorafenib Resistance in Acute Myeloid Leukemia by Targeting BCL2
por: Xu, Xi, et al.
Publicado: (2023)

A systems framework for vaccine design
por: Mooney, Michael, et al.
Publicado: (2013)

Visualization of drug target interactions in the contexts of pathways and networks with ReactomeFIViz
por: Blucher, Aurora S., et al.
Publicado: (2019)

Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
por: Halbach, Sebastian, et al.
Publicado: (2016)

Sorafenib Dose Recommendation in Acute Myeloid Leukemia Based on Exposure‐FLT3 Relationship
por: Liu, Tao, et al.
Publicado: (2018)

Occupancy Classification of Position Weight Matrix-Inferred Transcription Factor Binding Sites
por: Wright, Hollis, et al.
Publicado: (2011)

Multi-omic network signatures of disease
por: Gibbs, David L., et al.
Publicado: (2014)

Use of semantic workflows to enhance transparency and reproducibility in clinical omics
por: Zheng, Christina L., et al.
Publicado: (2015)

How I read an article that uses machine learning methods
por: Nazha, Aziz, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_foiih0ejrqqkicnoi6e2i154nq